Please come back soon for more information on speakers.
Born a Spanish citizen in Casablanca, Morocco, Taurel became an American citizen in November 1995. After graduating from École des Hautes Études Commerciales, in Paris, France, in 1969, he received a master of business administration degree from Columbia University in 1971. Taurel joined the Lilly subsidiary Eli Lilly International Corporation in 1971 as a marketing associate. He became general manager of the company's affiliate in Brazil in 1981 and was appointed to the London-based position of vice president of Lilly European operations in 1983. He was named executive vice president of Eli Lilly and Company and president of its pharmaceutical division in 1993. Three years later, he was promoted to president and chief operating officer. Taurel is past chairman and a member of the executive committee of the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA). He is also a member of the boards of IBM Corporation; McGraw-Hill Companies, Inc.; and the RCA Tennis Championships. And he is a member of the board of overseers of the Columbia Business School, a trustee at Indianapolis Museum of Art, and a member of The Business Council and The Business Roundtable. In early 2003, he was appointed to the President's Export Council to provide advice on international trade issues. He is an officer of the French Legion of Honor.
Personal Data Place of birth: Education: Office address: 3M Career Non-3M Affiliations: Business, Professional and Civic Organizations
Hawkins joined Medtronic from Novoste Corp., where he had been President and Chief Executive Officer since 1998. Earlier positions included Corporate Vice President and President of the Sherwood Davis and Geck organization of American Home Products; President of the Ethicon Endo-Surgery organization of Johnson & Johnson; President, Devices for Vascular Intervention and U.S. Operations, for Guidant Corp.; and several increasingly responsible executive positions culminating in the presidency of the Ivac organization for Eli Lilly & Co. He began his medical technology career with Carolina Medical Electronics in 1977. Hawkins received his Bachelor of Science degree in electrical and biomedical engineering from Duke University in 1976 where he also conducted medical research in pathology. He received a Master of Business Administration Degree from the Darden School of Business, University of Virginia, in 1982. Hawkins is a member of the Board of Visitors of the Engineering School of Duke University, the Guthrie Theatre Board; and a Trustee of the University of Virginia Darden School Foundation.
Since joining Cardinal Health in April 2006, Clark has focused the company – through organic growth, acquisition and divestiture – on the global opportunity to help hospitals, physicians and pharmacies make the practice and delivery of health care safer and more productive. Under his leadership, the company acquired medical technology leaders, MedMined and Care Fusion to bolster its patient-safety offerings, and divested a $2 billion business that developed, manufactured and packaged medicine for the pharmaceutical industry. Since Jan. 1, Cardinal Health shares have increased 13 percent. Internal programs instituted during Clark’s tenure reflect his passion for the development of leaders and the importance of innovation as a driver of organic growth. In addition, Clark’s global business experience helped shape Cardinal Health’s strategy to participate in the health-care industry worldwide, a market valued at more than $1 trillion. Today, less than 10 percent of company revenues are generated by the sale of products and services outside the U.S. He joined Cardinal Health from The Procter & Gamble Company, where he served as vice chairman of the board and was responsible for the company’s $20-billion Family Health business. During his 32-year career with P&G, Clark had considerable strategic, operational and corporate management experience and held leadership positions in North America and Asia. Since beginning his career with P&G in Canada as a brand assistant in 1974, he held positions of increasing responsibility, including group vice president of Laundry and Cleaning products, president of P&G Asia and president of Global Market Development and Business Operations. A native of Ottawa in Ontario, Canada, Clark graduated from Queen’s University with a bachelor of commerce degree. He is also a director of Textron, Inc.
Stephen Hemsley Mr. Hemsley earned a B.S. degree in accounting magna cum laude from Fordham University in 1974. He also played football at Fordham. Prior to joining UnitedHealth Group as senior executive vice president in 1997, Mr. Hemsley was managing partner in strategy and planning and chief financial officer for Arthur Andersen, LLP. Mr. Hemsley has served on numerous corporate and nonprofit boards, and is currently a member of the board of directors of UnitedHealth Group. Mr. Hemsley is also a lay member on the board of the Archdiocese of Saint Paul and Minneapolis. His philanthropic interests focus on health care, education and social services in the Twin Cities area.
Prior experience Tony joined Astra USA in 1997 as Vice President—Marketing and Sales. Prior to taking over as President and CEO, Zook was Senior Vice President—Commercial Operations for AstraZeneca LP, US, responsible for leading the company’s marketing and sales organizations. Education Affiliations
Mussallem has headed Edwards Lifesciences since it was spun off from Baxter International Inc. and began operating as an independent, publicly traded company (NYSE:EW) in April 2000. Previously, he was responsible for the worldwide operations of both Baxter’s CardioVascular business, which he had headed since 1995, and its Biopharmaceuticals business, which he had been appointed to lead in 1998. Mussallem joined Baxter in 1979 and progressed through a variety of increasingly responsible positions in manufacturing, engineering and product development. He was named president of Baxter’s Critical Care Division in 1993, and group vice president of Baxter’s Surgical Group in 1994. From 1996 through 1998, he chaired Baxter’s Asia-Pacific Board, which coordinated all of Baxter’s regional initiatives. Previously, he worked for Union Carbide. Mussallem currently serves as a member of the board of directors for Advanced Medical Optics, Inc. He also serves on the boards and executive committees of the California Healthcare Institute, OCTANe, and the Advanced Medical Technology Association (AdvaMed). Mussallem is also a member of the UCI Chief Executive Roundtable. He received a bachelor’s degree in chemical engineering in 1974 and an honorary doctorate in 1999 from the Rose-Hulman Institute of Technology in Terre Haute, Indiana.
Dr. Nabel joined the National Heart, Lung, and Blood Institute (NHLBI) in 1999 as the Institute’s Scientific Director of Clinical Research. In 2005, Dr. Nabel became Director of NHLBI, where she oversees an extensive national research portfolio of basic and clinical research to prevent, diagnose, and treat heart, lung, and blood diseases. The Institute also conducts educational activities for health professionals, patients, and the general public. The NHLBI budget for fiscal year 2006 is approximately $2.9 billion. Dr. Nabel has made many contributions to basic and clinical research on the pathogenesis and treatment of cardiovascular diseases. She has devoted several decades to exploring genes that contribute to vascular disease and strategies for gene transfer to benefit patients with those diseases. She has delineated the mechanisms that regulate the vascular proliferation and remodeling which lead to blood vessel blockages. Her research now focuses on the role of genetic factors in blood vessel diseases, including atherosclerosis and Hutchinson Gilford Progeria Syndrome, a rare, premature aging syndrome. Dr. Nabel has served as a Visiting Professor at major medical centers throughout the country and delivered major lectureships in Europe and Australia. She has received numerous awards for her scientific accomplishments, including the Willem Einthoven Award from Leiden University in the Netherlands, the Amgen-Scientific Achievement Award from the American Society for Biochemistry and Molecular Biology, and Distinguished Achievement Awards from the Basic Cardiovascular Sciences Council and the Atherosclerosis, Thrombosis, and Vascular Biology Council of the American Heart Association. In 2001, she received an honorary doctorate from the University of Leuven, Belgium and in 2006 from Mt. Sinai School of Medicine, New York. Dr. Nabel is an elected member of the Institute of Medicine of the National Academy of Sciences, the American Society of Clinical Investigation, and the Association of American Physicians, as well as a Fellow of the American Heart Association and the American College of Cardiology. She serves on the editorial board of many scientific journals, including being an editorial board member of the New England Journal of Medicine, past Board of Reviewing Editors for Science, and associate editor for the Journal of Clinical Investigation. A partner on 13 patents, Dr. Nabel is the author of more than 200 scientific publications, and she has mentored more than 45 students and fellows.
Ms. Poon began her career with Johnson & Johnson in November, 2000, as Company Group Chairman, Pharmaceuticals. In August, 2001, she was promoted to the Executive Committee and named Worldwide Chairman, Pharmaceuticals. Ms. Poon was appointed Worldwide Chairman, Medicines & Nutritionals, in October 2003. She was named a Vice Chairman of the Board in January 2005 and was elected to the Johnson & Johnson Board of Directors in April, 2005. Prior to joining Johnson & Johnson, Ms. Poon spent 15 years at Bristol-Myers Squibb where her most recent position was President of International Medicines. Her career at Bristol-Myers Squibb included marketing and strategic planning positions. In 1990 she was named Vice President, Cardiovascular Strategic Product Planning, and she became Vice President and General Manager of Squibb Diagnostics in 1992. In 1994 she was named President and General Manager of the Canadian operation. She was named Vice President, then Senior Vice President for Canada and the Latin America Pharmaceutical Operations, and from 1997-1998 she was President of Medical Devices. Ms. Poon is on the Board of Directors of Prudential Financial, Inc., in Newark, NJ, and the Fox Chase Cancer Center in Philadelphia, PA. She is a past member of the Board of Trustees of the NJ Institute of Technology. In 2004 she was named Woman of the Year by the Healthcare Businesswomen’s Association and in November 2005 was named Business Leader of the Future by CNBC/Wall Street Journal. Born in Brentwood, Missouri, Ms. Poon received a bachelor's degree in biology from Northwestern University, a master's degree in biology/biochemistry from St. Louis University and an M.B.A. in finance from Boston University. Ms. Poon is married and resides in Princeton, NJ.
Cook became a U.S. Army medic in 1953 and taught Physics of Anesthesia to Army resident anesthesiologists. His career in business started in 1955 as an engineering recruiter for Martin Aircraft; later he became a catalog editor and scientific products salesman for American Hospital Supply Corporation. In 1958, in Chicago, he co-founded MPL Incorporated, which became the third largest hypodermic needle manufacturer in the United States. In 1963 Cook Incorporated was founded in Bloomington, Indiana, on $1500 invested capital, with Bill and his wife Gayle as its only employees, and with percutaneous wire guides, catheters and needles as its first products. The company has become a conglomerate, Cook Group Incorporated, with manufacturing facilities in the United States, Australia, Denmark, and Ireland, and with sales organizations throughout the world. Fifty companies form Cook Group Incorporated. The firms manufacture cardiovascular, critical care, diagnostic and interventional products, extruded and injection-molded plastics, stainless steel tubing, urological equipment, OB/GYN devices, and endoscopic instruments. In addition, other corporations are involved in real estate, historic restoration, antiques, travel, and aircraft service. He was founder of the Monroe County YMCA, now the largest in Indiana, and was sponsor of the Star of Indiana Drum and Bugle Corps, a traveling and performing group of young people. He also produced the Tony and Emmy winning Broadway show Blast whose roots came from the drum and bugle corps activity. This musical hit show has toured the United States and the world since the fall of 1999. To aid the advancement of education and medical research, Cook companies have provided significant financial support to universities, hospitals and physicians throughout the country. Bill has received honorary degrees from Rose-Hulman Institute of Technology, Indiana University, Vincennes University, and Northwestern University. He was the first non-physician to receive the Gold Medal from the Society for Interventional Radiology, and he recently received the Cor Vitae Award from the American Heart Association for his contributions to cardiovascular health care. In July, 2006, was named an Indiana Living Legend by the Indiana Historical Society. In addition, he has been awarded historic preservation honors from the National Trust for Historic Preservation, National Park Service, Historic Landmarks Foundation of Indiana, the Indiana Department of Natural Resources, and the City of Bloomington. In July 2007, he received the Indiana Living Legend Award from In 1999 The Indiana Chamber of Commerce named him the Indiana Business Man of the year, and in 1992 he was inducted into the Junior Achievement Central Indiana Business Hall of Fame. A stadium, a music library, and a science hall bear the Cook name at Rose-Hulman, Indiana, and Northwestern universities. Other honors include numerous community service, historic preservation, business, and productivity awards. The city of Canton, Illinois, twice honored him for his restoration of thousands of trees after a tornado devastated the town. Bill served as a trustee of Indiana University, is a licensed jet pilot, contributed to numerous books and periodicals, and holds various patents, including a rate-responsive pacemaker.
Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and vice president and general manager of Bioabsorbable Vascular Solutions. He also served as vice president and general manager of Guidant Germany and vice president, marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Capek was manager of New Product Technology at Eli Lilly & Company. Capek has a bachelor's degree in biomedical engineering, a master's degree in biomedical engineering, a master's degree in electrical engineering, a Ph.D. in biomedical engineering and a master's degree in business administration from Rensselaer Polytechnic Institute.
Larry King Live debuted on CNN in June 1985, featuring its now-famous mix of celebrity interviews, political debates and topical discussions. When King made the transition from his successful national radio talk show to cable, he helped define the future of cable news programming and CNN. In 1987, Larry King awoke in the Intensive Care Unit of a New York hospital after undergoing successful quintuple bypass heart surgery. For almost a year, his heart had been failing as a result of cardiovascular disease. Larry was lucky. His hospital bills were covered by insurance. It was while he was recovering from his operation that he made a promise to himself to help others who may not be as fortunate. The Larry King Cardiac Foundation (LKCF) was established in 1988 as a 501(c)(3) tax-exempt organization. Its mission is to provide funding for life-saving treatment for individuals who, due to limited means or inadequate insurance, would otherwise be unable to receive vital cardiac care or surgical procedures. The Larry King Cardiac Foundation has established vital partnerships with premier cardiac care medical centers like the Cleveland Clinic to access and identify potential candidates for medical care. As partners with The Larry King Cardiac Foundation, The Cleveland Clinic has made a commitment to providing our patients with the most accurate information, newest techniques and latest developments in fighting heart disease. While Mr. King has done more than 40,000 interviews throughout his half century in broadcasting, including exclusive sit-downs with every U.S. president since Gerald Ford he has described his work with the Cardiac Foundation as his most rewarding. King is married to singer/actress Shawn Southwick-King and is the father of Andy, Larry Jr., Chaia, Chance and Cannon and stepfather to Danny Southwick.
Johnson's programs and feature reports have won several awards, including an Emmy Award from the National Academy of Television Arts and Sciences as well as two Emmy Awards from the Boston/New England Chapter of the same organization. In 1999, he earned a Gabriel Award in the best news story category for the two-part piece, "Alzheimer's: A Faded Memory." Johnson was selected as the recipient of the 1998 Bradford Washburn Award presented by the Museum of Science, Boston -- an honor also bestowed upon Jacques Cousteau, Walter Cronkite, Dr. Jane Goodall and Alan Alda, among others. In 1988, he received the Lewis Thomas Award for Communications from the American College of Physicians, and in 1987 and 1989, he won the Howard W. Blakeslee Award given by the American Heart Association. Johnson is the founding editor of the Harvard Medical School Health Letter and co-editor of the "Harvard Medical School Health Letter Book." He is also co-editor of the book "Your Good Health," co-author of "Let's Talk," and author of "Dr. Timothy Johnson's OnCall Guide to Men's Heath" and "Finding God in the Questions: A Personal Journey." Originally headed for the ministry, he graduated in from North Park Seminary in 1963, then decided two years later to enter medicine. A Phi Beta Kappa graduate of Augustana College, he graduated summa cum laude from Albany Medical College and holds a masters degree in public health from Harvard University. He is on the faculty at Harvard Medical School and is a former staff member of Massachusetts General Hospital, among other institutions. Johnson is married, and is the father of two children and one grandchild.
He joined The New York Times in 1980 as a technology reporter. From 1982 to 1985, he was the paper's business reporter in London, covering the U.K., Ireland, Scandinavia and, on occasion, the Benelux countries. He served as Midwest business correspondent based in Chicago from 1992-98. He has also done several short stints editing in Business Day. Prior to joining the Times, Barnaby's newspaper career included six months at World Business Weekly (a Financial Times publication that was later shut down), two years at Energy User News (a Fairchild weekly), nine months as a freelance reporter in Scandinavia, and two years with the North Adams (Mass.) Transcript. Barnaby is a 1977 graduate of the University of California at Berkeley Law School (Boalt Hall). He is a native of San Mateo, Cal. He received his undergraduate B.A. from Williams College in 1972. He and his wife, Michele, have three children.
Silberner has been with NPR since 1992. Prior to that she spent five years covering consumer health and medical research at U.S. News & World Report. In addition she has worked at Science News magazine, Science Digest, and has freelanced for various publications. She has been published in The Washington Post, Health, USA Today, American Health, Practical Horseman, Encyclopedia Britannica, and others. She was a fellow for a year at the Harvard School of Public Health, and from 1997-1998, she had a Kaiser Family Foundation media fellowship. During that fellowship she chronicled the closing of a state mental hospital. Silberner also had a fellowship to study the survivors of the bombings of Hiroshima and Nagasaki. Silberner has won awards for her work from the Society of Professional Journalists, the New York State Mental Health Association, the March of Dimes, Easter Seals, the American Heart Association, and others. Her work has also earned her a Unity Award and a Clarion Award. A graduate of Johns Hopkins University, Silberner holds her B.A. in biology. She has a master's degree in journalism from Columbia University Graduate School of Journalism. She currently resides in Washington, D.C.
McCurry is a veteran communications strategist and spokesperson with three decades of experience in Washington D.C. McCurry served in the White House as Press Secretary to President Bill Clinton (1995-1998). He also served as Spokesman for the Department of State (1993-1995) and Director of Communications for the Democratic National Committee (1988-1990). McCurry has also held leadership roles in several national campaigns -- senior advisor for Senator John Kerry (2004), national press secretary for the vice presidential campaign of Senator Lloyd M. Bentsen (1988), and spokesman and political strategist in the presidential campaigns of Senator John Glenn (1984), Governor Bruce Babbitt (1988) and Senator Bob Kerrey (1992). McCurry began his career on the staff of the United States Senate, working as press secretary to the Senate Committee on Labor and Human Resources and to the committee's chairman, Senator Harrison A. Williams, Jr. (1976-1981). He also served as press secretary to Senator Daniel Patrick Moynihan (1981-1983). In the private sector, he served as public affairs director for the ERISA Industry Committee (1984-85) and as senior vice president of the consulting firm then known as Robinson, Lake, Lerer, & Montgomery (1989-92). McCurry serves on boards or advisory councils for Share Our Strength, the Center for International Private Enterprise, the Council for Excellence in Government, the Junior Statesmen Foundation, the Children’s Scholarship Fund, the Wesley Theological Seminary, and the Woodrow Wilson School of Public and International Affairs at Princeton University. McCurry also serves as an advisor to Grassroots Enterprise, Inc. a firm that specializes in using the Internet to mobilize citizens for effective public action. McCurry received his Bachelor of Arts from Princeton University in 1976 and a Master of Arts in Liberal Studies from Georgetown University in 1985.
Bill received his B.S. in Biology and Chemistry from Tufts University, his M.D. from Harvard Medical School and his M.B.A from the University of California at Berkeley. Bill is a C.F.A. charterholder.
Additionally, Rich has been a successful CEO of two publicly traded medical technology companies. Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters which was eventually acquired for $125 million by Boston Scientific. His most recent success, CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery, was acquired by Guidant for $350 million in November 1999. Rich was a co-founder of CTS and the force that led the company to an initial public offering in only 7 months, the fastest of any medical technology company in history. Mr. Ferrari also Co-Founded the Medical Technology Group which spun-out Integrated Vascular Systems, acquired by Abbot Vascular and Ensure, acquired by J&J. Previously Mr. Ferrari held the positions of Executive Vice President and General Manager of ADAC Laboratories. In 1996 he founded Saratoga Ventures, a venture capital partnership that has provided seed financing to startup medical technology companies. Mr. Ferrari is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. Rich holds a BS degree from Ashland University and an MBA from the University of South Florida.
Mr. Rein attended Emory University and Oglethorpe College (1968) and holds an M.B.A. from the Darden School at the University of Virginia (1973).
Sidney Cohen,
MD, PhD
Since founding the company, Dr. Hassanein has raised over $66 million of private equity capital to commercialize the Organ Care System and recruited the world's thought leaders in transplant medicine as scientific advisors and clinical collaborators. Dr. Hassanein is a frequent presenter at business and entrepreneurship symposiums and has presented his research at national and international transplant conferences. He is the author of numerous scientific manuscripts and publications in peer-reviewed journals. His achievements have been recognized by the by the American Association for Thoracic Surgery. Dr. Hassanein received his M.D. from Georgetown University where he also completed two years of General Surgery residency. He then completed a three-year Cardiac Surgery Research fellowship at West Roxbury VA Medical Center, a Harvard Medical School Affiliate.
In 2000, Bonnie joined Welch Allyn, Inc. as Group Vice President. At Welch Allyn she was responsible for the Electronic Vital Signs, Cardiopulmonary, and Integrated Workstations businesses, as well as EMEA (Europe, Middle East & Africa) sales and marketing. She also served on the Welch Allyn corporate Executive Committee and corporate Leadership Team. Bonnie is currently President and CEO of Cardiac Concepts, Inc., a Minneapolis based company with venture capital backing, developing new medical device technologies. Bonnie received her B.A. in mathematics from Mercyhurst College in Erie, PA, her M.S. in mathematics from the University of Notre Dame, and her M.S. in computer science from the University of Minnesota. She participated in the Executive Development Program at the Carlson School of Management at the University of Minnesota and the Tuck Executive Program at the Tuck School of Business at Dartmouth.
From 1995-2000, Mr. Berman was the President of the Cardiology Business of Boston Scientific. He graduated from Cornell University 1979 and received an MBA from Cornell University in 1986.
Bram Zuckerman,
MD
His laboratory reported the first purified angiogenesis molecule, the first angiogenesis inhibitor and proposed the concept of angiogenic disease. All of these discoveries have been translated into numerous clinical trials. Ten angiogenesis inhibitors are now approved by the FDA in the U.S., and several angiogenesis inhibitors are also approved in 30 other countries for the treatment of cancer and macular degeneration. Largely because of Dr. Folkman's research, the possibility of antiangiogenic therapy is now on a firm scientific foundation, not only in the treatment of cancer, but of many non-neoplastic diseases as well. Dr. Folkman's exceptional achievements have been recognized by many national and international awards. In 1990, he was elected to the National Academy of Sciences. He is also a member of the American Academy of Arts and Sciences, the American Philosophical Society, the Institute of Medicine of the National Academy of Sciences and has a Presidential appointment to the National Cancer Advisory Board of the National Institutes of Health. In addition to his distinguished accomplishments in research, Dr. Folkman has served as a surgeon and teacher. He began his career as an Instructor in Surgery for Harvard's Surgical Service at Boston City Hospital, was promoted to Professor of Surgery at Harvard Medical School, and became the Julia Dyckman Andrus Professor of Pediatric Surgery in 1968. From 1967 he served as Surgeon-in-Chief at Children's Hospital Boston for 14 years. He is the Director of the Vascular Biology Program in the Department of Surgery at Children's Hospital. He holds honorary degrees from 18 universities and is the author of more than 400 original peer-reviewed papers and 109 book chapters and monographs.
He won the Nobel Memorial Prize for Economic Science in 1992, the National Medal of Science in 2000, the John Bates Clark Medal of the American Economic Association in 1967, and many other awards. He is recognized for his expertise in human capital, economic incentives, economics of the family, and economic analysis of crime, discrimination, and population. For almost 20 years he was a featured monthly columnist for Business Week Magazine. He and Judge Richard Posner have a blog at http://www.becker-posner-blog.com/, where every week they debate a public policy issue. He has written more than ten books and almost 100 professional articles. His books include Human Capital, The Economics of Discrimination, The Economic Approach to Human Behavior, A Treatise on the Family, The Economics of Life (with Guity Nashat Becker), Social Economics (with Kevin Murphy), and Accounting for Tastes. His books have been translated into Chinese, French, German, Italian, Japanese, Russian, Spanish, and other languages. He is a member of the Board of Faster Cures-dedicated to speeding up medical cures, the Board of the Manhattan Institute-a think tank on public policy, the Advisory Committee on Financial Innovation of the Chicago Mercantile Exchange, and the Economic Council that advises Governor Schwarzenegger of California. He was an economic adviser to Senator Robert Dole when he ran for president in 1996. He has lectured to many groups of academics, business executives, and government officials.
David received his, BA in Biology/Chemistry (1969) and MA, Molecular Biology (1973) from Hunter College of CUNY, and Ph.D. in biology/biochemistry from St. John’s University/SUNY Downstate Medical in 1980. He was a postdoctoral fellow at the New York Blood Center from late 1979-1981in Hematology and cell biology, assistant professor of Medicine at U of Wisconsin Medical School from 1981-1986, associate professor at the Medical School and U of Wisconsin-Milwaukee from 1987-1990, and full professor at both institutions until 1997. He remains affiliated with U of Wisconsin as an adjunct Full Professor. Dr. Amrani’s past and present research has focused on research and clinical hematology and hemostasis including an expertise in blood-derived stem cells, fibrin(ogen) and platelets, and biomaterial-device hemocompatibility. He serves as a reviewer for a number of journals including Blood Coagulation and Fibrinolysis, J. Biol. Chem., Blood, and Transfusion. He is currently on the board of directors of the International fibrinogen Society, Illinois Institute of Technology, Chicago Technology Park (CTP), and U. of Illinois College of Medicine at Rockford.
For the past 30 years, Dr. Ornish has directed clinical research demonstrating, for the first time, that comprehensive lifestyle changes may begin to reverse even severe coronary heart disease, without drugs or surgery. Recently, Medicare agreed to provide coverage for this program, the first time that Medicare has covered a program of comprehensive lifestyle changes. He recently directed the first randomized controlled trial demonstrating that comprehensive lifestyle changes may stop or reverse the progression of prostate cancer. His current research is focusing on whether comprehensive lifestyle changes may affect gene expression. He is the author of five best-selling books, including New York Times’ bestsellers Dr. Dean Ornish's Program for Reversing Heart Disease, Eat More, Weigh Less, and Love & Survival. He writes a monthly column for both Newsweek and Reader’s Digest magazines. The research that he and his colleagues conducted has been published in the Journal of the American Medical Association, The Lancet, Circulation, The New England Journal of Medicine, the American Journal of Cardiology, and elsewhere. A one-hour documentary of their work was broadcast on NOVA, the PBS science series, and was featured on Bill Moyers' PBS series, Healing & The Mind. Their work has been featured in all major media, including cover stories in Newsweek, Time, and U.S. News & World Report. Dr. Ornish is a member of the boards of directors of the U.S. United Nations High Commission on Refugees, the Quincy Jones Foundation, and the San Francisco Food Bank, and a member of the Google Health Advisory Council. He was appointed to The White House Commission on Complementary and Alternative Medicine Policy and elected to the California Academy of Medicine. He is Chair of the PepsiCo Blue Ribbon Advisory Board and the Safeway Advisory Council on Health and Nutrition and consults directly with the CEO’s of McDonald’s and Del Monte Foods to make more healthful foods and to provide health education to their customers in this country and worldwide. He has received several awards, including the 1994 Outstanding Young Alumnus Award from the University of Texas, Austin, the University of California, Berkeley, “National Public Health Hero” award, the Jan J. Kellermann Memorial Award for distinguished contribution in the field of cardiovascular disease prevention from the International Academy of Cardiology, a Presidential Citation from the American Psychological Association, the Beckmann Medal from the German Society for Prevention and Rehabilitation of Cardiovascular Diseases, the “Pioneer in Integrative Medicine” award from California Pacific Medical Center, the “Excellence in Integrative Medicine" award from the Heal Breast Cancer Foundation, the Golden Plate Award from the American Academy of Achievement, a U.S. Army Surgeon General Medal, and the Bravewell Collaborative Pioneer of Integrative Medicine award. Dr. Ornish has been a physician consultant to The White House and to several bipartisan members of the U.S. Congress. He is listed in Who’s Who in Healthcare and Medicine, Who’s Who in America, and Who’s Who in the World. Dr. Ornish was recognized as “one of the most interesting people of 1996” by People magazine, featured in the “TIME 100” issue on integrative medicine, and chosen by LIFE magazine as “one of the 50 most influential members of his generation.”
Among the seemingly countless positions of distinction that he holds are Past President of the American Heart Association, Immediate Past President of the World Heart Federation, a member of the Institute of Medicine of the National Academy of Sciences, a former member of the National Heart, Lung and Blood Institute Advisory Council, and former Chairman of the Fellowship Training Directors Program of the American College of Cardiology. Seventeen distinguished universities throughout the world have granted him honoris causa. Dr. Fuster is President of the Scientific Advisory and External Evaluation Committee at the Fundacion Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, Spain Dr. Fuster is the only cardiologist to receive all four major research awards from the four major cardiovascular organizations: The Distinguished Researcher Award (Interamerican Society of Cardiology, 2005), Andreas Gruntzig Scientific Award (European Society of Cardiology, 1992), Distinguished Scientist (American Heart Association, 2003), and the Distinguished Scientist Award (American College of Cardiology, 1993). In addition, he has received the Lewis A. Conner Memorial Award by the American Heart Association, the James B. Herrick Achievement Award from the Council of Clinical Cardiology of the American Heart Association, the 1996 Principe de Asturias Award of Science and Technology (the highest award given to Spanish-speaking scientists), the Distinguished Service Award from the American College of Cardiology, the Gold Heart Award (American Heart Association's highest award), and the Gold Medal of the European Society of Cardiology (the highest of the Society, to be received in Vienna, September 2007). After receiving his medical degree from Barcelona University and completing an internship at Hospital Clinic in Barcelona, Dr. Fuster spent several years at the Mayo Clinic, first as a resident and later as Professor of Medicine and Consultant in Cardiology. In 1981, he came to Mount Sinai School of Medicine as head of Cardiology. From 1991 to 1994, he was Mallinckrodt Professor of Medicine at Harvard Medical School and Chief of Cardiology at the Massachusetts General Hospital. He returned to Mount Sinai in 1994 as Director of the Zena and Michael A. Wiener Cardiovascular Institute and most recently, he has been named the Director of the Mount Sinai Heart.
After receiving his B.A. and M.S. degrees from Brown University in Rhode Island, Dr. Cox obtained his M.D. and Ph.D. degrees from the University of Washington, Seattle. He then completed his Pediatric Residency at the Yale-New Haven Hospital in New Haven, Connecticut and was a Fellow in both genetics and pediatrics at the University of California San Francisco. From 1980 to 1993, Dr. Cox held faculty positions in the Departments of Pediatrics, Biochemistry and Psychiatry at the University of California San Francisco. In 1993, he accepted a position as a Professor of Genetics and Pediatrics at the Stanford University School of Medicine as well as the Co-director of the Stanford Genome Center. In October of 2000, Dr. Cox left his position at Stanford University to become the Chief Scientific Officer of Perlegen Sciences, Inc. Dr. Cox is certified by both the American Board of Pediatrics and the American Board of Medical Genetics. He has served on several international and national councils and commissions including the Council of the Human Genome Organization (HUGO) and the National Bioethics Advisory Commission (NBAC). He presently serves as a member of the Health Sciences Policy Board of the Institute of Medicine. Dr. Cox’s honors include election to the Institute of Medicine of the National Academy of Sciences.
Dr. Firlik is a founder and an inventor of the core technology platform of Northstar Neuroscience (NASDAQ: NSTR), a medical device company that is pioneering a novel approach to neuromodulation for the treatment of stroke and other disorders. He is currently the Chairman of NovaVision, a medical therapeutics firm focusing on neuroplasticity for visual disorders. He also currently serves on the board of directors of several companies, including NeuroVista, Spine Wave, BridgePoint Medical, Innovative Metabolics, and Visiogen. Dr. Firlik is a member of the Life Sciences Advisory Board of Cornell University and the Industrial Advisory Board of Cleveland Clinic Foundation Innovations Center. Dr. Firlik spent 12 years in the healthcare profession during his medical training and practice as a neurological surgeon. He has published more than 50 articles in the medical literature, written chapters for several medical textbooks, and is the co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences. He has been an inventor of numerous patents. He studied biology at Cornell University and Oxford University, received his MBA from the University of Pittsburgh, and his MD from Cornell University Medical College. As a board certified neurosurgeon, Dr. Firlik most recently served as Clinical Assistant Professor of Neurosurgery at the New York University School of Medicine.
LeRoy LeNarz,
MD
Dr. Steinhaus has been closely associated with research and academia, performing extensive clinical study in implantable cardiac devices and leads. He has over 100 publications in peer-reviewed journals and has testified several times for government committees and hearings. Steinhaus served as Chair of the Department of Cardiology, and Director of the Electrophysiology Department at Mid America Heart Institute and St. Luke’s Hospital, Director of the Electrophysiology Fellowship Program at the University of Missouri at Kansas City School of Medicine and Mid America Heart Institute, Saint Luke’s Hospital, and has instructed students in medicine since 1982. A 1973 magna cum laude graduate of Harvard College, Steinhaus received his medical doctorate from Harvard Medical School as part of the Harvard-M.I.T. program in Health Sciences and Technology, with AOA honors. He completed his internship, residency, and a clinical and research fellowship in cardiology and cardiac electrophysiology, in the Department of Medicine at Massachusetts General Hospital, Boston, MA. Dr. Steinhaus is the immediate past President of the North American Society of Pacing and NASPExAM. He also led the Heart Safe Community Project to place automated external defibrillators in public places and to increase public awareness of sudden cardiac arrest. In the community, he has served as President of the board of the Friends of Chamber Music in Kansas City.
In this newly created division, he will oversee Cleveland Clinic’s strategic ventures and emerging businesses worldwide, including the evaluation, selection, growth, and operation of new services, products and business opportunities contributing to Cleveland Clinic’s expanded presence throughout the United States and abroad. His specific responsibilities will include: the development and leadership of CCF Innovations and Cleveland Clinic’s international businesses; directing the creation and implementation of the Clinic’s wellness strategies; leadership and management of existing and future business partnerships and strategic ventures; development of business vehicles for the commercialization of Cleveland Clinic’s intellectual property; further development of the Clinic’s franchising and consulting businesses, and the evaluation and development of other emerging businesses pursued by the Clinic Prior to joining the Clinic, he served as President and Chief Executive Officer of LifeMasters. As CEO he was responsible for developing overall company strategy, managing the company’s day-to-day operations, strengthening the company’s infrastructure, developing products and services to meet the needs of new and emerging markets and preparing the company for future growth. Prior to joining LifeMasters, Mr. Strand was Chief Operating Officer of Allina Health Systems in Minneapolis MN where he was responsible for all Allina operations including Allina hospitals, Allina medical clinics, Medica and all ancillary Allina businesses. He also served as President of Medica Health Plans, one of the nation’s largest independent health plans. During his tenure as President, Medica doubled its members in Minnesota, North Dakota, South Dakota, and Wisconsin to over 1 million members, achieved the highest quality accreditation from the National Committee for Quality Assurance (NCQA) and was rated by Weiss as one the nation’s top 5 health plans for financial strength. David is currently Vice Chair of the Board of Trustees for both Minnesota Public Radio and American Public Media Group. Mr. Strand graduated magna cum laude with a Bachelor of Arts from Gustavus Adolphus College and cum laude with a Juris Doctor from the University of Minnesota Law School.
Eric Schadt, PhD
Dr. Roizen is a past chair of a Food and Drug Administration advisory committee and a former editor for six medical journals. He has published more than 160 peer-reviewed scientific papers, 100 textbook chapters, 30 editorials, and 4 medical books, (one, a medical Best-seller), and received 13 U.S. and many foreign patents. After 9 years on the faculty at the University of California, San Francisco, he chaired the top-10-rated department of Anesthesia and Critical Care at the University of Chicago. He then became dean of the School of Medicine and vice president for Biomedical Sciences at SUNY Upstate. After serving as CEO of the Biotechnology Research Corporation of Central New York, he accepted his current position as chair of the Division of Anesthesiology, Critical Care Medicine, and Comprehensive Pain Management at the Cleveland Clinic, responsible for over 180 operatories, 124 critical care beds and 28 pain therapy intervention units. His first general audience book, RealAge: Are You as Young as You Can Be? (HarperCollins Publishers) became a #1 New York Times bestseller and was awarded the Best Wellness Book of 1999 by the Books for a Better Life Awards. RealAge has been translated into more than 20 languages and was #1 in four other countries, displacing Harry Potter for 7 days as #1 on Amazon. Other books include the New York Times bestseller The RealAge Diet: Make Yourself Younger with What You Eat (HarperCollins), written with Dr. John La Puma, Cooking the RealAge Way (Harper Collins), also with Dr. La Puma., and The RealAge Makeover (HarperCollins). His book, YOU: The Owner’s Manual (HarperCollins), written with Health Corps founder Dr. Mehmet Oz, debuted in May 2005 and became a #1 New York Times bestseller (sold more than 2.7 million hardcover copies worldwide; was the #2 best selling book published in 2005 in 2005-- displacing Harry Potter for 35 days as #1 on Amazon & BN.com.). It was followed by the NY Times bestseller YOU: The Smart Patient. Their latest book, YOU: On A Diet, the Owner’s Manual for Waist Management, debuted at #1 on the New York Times list (11 consecutive weeks at #1 and 17 consecutive weeks in top 3 as of now) with 2 1printings totaling over 2.4 million copies in the first three weeks ( it is the #2 best selling book published in 2006 in 2006). Dr. Roizen has given over 1,400 lectures to professional medical groups and has been recognized with over 20 professional lectureships. He has appeared on The Oprah Winfrey Show 11 times, Today 17 times, 20/20 (3 times), CBN (14 times), CNN, CBS, Good Morning America (19 times), Canada AM (23 times), The Montel Williams Show, Larry King Live, and has three PBS fundraising specials (his fundraising special The RealAge Makeover was one of the top two PBS special fundraisers in 2006, with over 4000 showings in 100 TV markets). He and Mehmet Oz write a monthly column for Reader’s Digest, and record 1 hour a day of radio for Oprah and Friends, XM channel 156. He also has a 2-hour 33 station Terrestrial show entitled: YOU The Owner’s Manual Radio Show, live every Saturday. He has been featured in Fortune, O, Glamour, Cosmo, Good Housekeeping, Ladies’ Home Journal, Biography, People, US, Men’s Health, & Prevention. Dr. Roizen still practices anesthesiology and internal medicine, using the RealAge metric to motivate his patients. He has personally delivered medical care to 8 Nobel Prize winners, more than 496 ex-smokers, over 100 Fortune 500 CEOs and CFOs, and countless others. He chaired the United Way Fund Raising effort at the Cleveland Clinic in 2006, and has served on the boards of five non-profit foundations. He served as President of the Society of Cardiovascular Anesthesiologists in 1997-8, and has won over 75 trophies in class A squash competition. He has been in the Best Doctors in America since 1989. His wife is a developmental pediatrician also listed in the Best Doctors in America. He and his wife are avid CAVs fans. The Roizens have two children: Jenny, a recent Williams graduate and PhD graduate student at California Institute of Technology, and Jeffrey, an MD/PhD student at Washington University.
Dr. Rodgers is currently the President & Chief Medical Officer of Biophysical Corporation, an Austin, TX-based company dedicated to advancing clinical knowledge through its research in the field of biomarkers. He continues to practice clinical cardiology with Austin Heart. Dr. Rodgers has been in private practice as a cardiologist in Austin since 1989. During that time he has served on numerous local and national committees on cardiovascular disease. Dr. Rodgers was elected Chair of the American College of Cardiology Board of Governors for 2007 and is a member of the ACC/ACCF Executive Committee and ACC Board of Trustees effective March 2006. Dr. Rodgers serves on the Board of Governors Steering Committee, Clinical Competency Task Force and the EBCT Writing Committee with the American College of Cardiology. Dr. Rodgers is currently the President of the Texas Chapter of the American College of Cardiology. Dr. Rodgers is on the editorial board of the American Heart Hospital Journal. He has published over forty articles on cardiovascular disease and has been the principal investigator on numerous research projects. Dr. Rodgers has a special interest in the early detection and treatment of atherosclerosis and is a founding member of the Society of Atherosclerosis Imaging. He initiated the first hypertrophic cardiomyopathy screening program for student athletes in Central Texas. Dr. Rodgers was President of Austin Heart, the premier cardiology group in Central Texas from 1999-2004. He was the Medical Director for the Heart Hospital of Austin in 2004 which was recently designated a center of excellence for United HealthCare. He continues to serve as President of the Austin Heart Foundation whose mission is to serve the greater Austin community in cardiovascular care.
Secretary of Defense (1997-2001)
In 1974, during his very first term in Congress, TIME magazine named Secretary Cohen as one of "America's 200 Future Leaders". This reflected, in part, the national prominence Secretary Cohen attained as a freshman Republican Congressman who was tasked by the House Judiciary Committee to build, on national television, the evidentiary base for impeachment of President Nixon -- and who then cast one of the critical votes to impeach. Internationally, Secretary Cohen's reputation also took root as he traveled to Thailand in 1974 to reassure a stalwart ally following the U.S. military withdrawal from Vietnam. In 1978, he was propelled into the Senate, defeating a highly respected incumbent. During his first weeks in the Senate, he was singled out to be chairman of two powerful subcommittees, the Armed Services Committee's Seapower and Force Projection Subcommittee and the Governmental Affairs Committee's Government Oversight Subcommittee. As Chairman of the Senate Committee on Aging, Secretary Cohen led efforts to improve the efficiency of Medicare and other health care programs and was a central player in the health care reform debates of the 1990s. In 1996, widely expected to easily defeat whomever would be nominated to challenge him, Secretary Cohen stunned Maine and Washington by announcing he would not seek re-election. Frustrated with partisan gridlock, Secretary Cohen announced he would return to private life to promote international business and, through his writings and the media, a more thoughtful public discourse on national political issues. He also launched the William S. Cohen Center for International Policy and Commerce at the University of Maine. President Clinton interrupted these plans, however, when he asked Secretary Cohen to lead the Department of Defense, the first time in modern U.S. history when a President has chosen an elected official from the other party to be a member of his cabinet. At his January 1997 confirmation hearing, Secretary Cohen set forth his prioritized objectives as Secretary and completed his tenure having accomplished them all. Reversing a steady decline in defense budgets that began in the 1980s, Secretary Cohen succeeded in modernizing the military and maintaining its readiness to fight; reversing recruitment and retention problems by enhancing pay and other benefits; and strengthening security relationships with countries around the world in order to reorient them from the Cold War to the challenges of a new era. A published author of eleven works of nonfiction, fiction, and poetry; a futurist with degrees in classical Latin and Greek; the son of a working-class family who rose to the highest levels in government, it was natural for the Christian Science Monitor to call him "a true Renaissance Man." He is also an accomplished athlete. After 31 years of public service, Secretary Cohen leaves behind a record of unparalleled accomplishment, integrity, and respect, and takes with him unrivaled knowledge, reputation, and relationships, across America and around the globe.
While serving as NCI Director, he helped launch a number of large-scale clinical trials related to the prevention, diagnosis, and treatment of cancer and inaugurated the SPORE Program. He is the author or co-author of over 330 scientific publications. He has received numerous scientific awards related to his research in cancer and AIDS. His current interests relate to applying knowledge of the human genome, DNA diagnostics, and proteomics to the development of new strategies to treat cancer.
|
|
Cleveland Clinic | Cleveland Clinic Innovations | Summit Home | Agenda | Setting | Registration | Sponsors | News and Media | Exhibitors | Past Summits Join Email List |
